Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of dabigatran etexilate in patients with mechanical bileaflet heart valves
2011-002285-21Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dabigatran in mechanical heart valve and cardiac morbidity, sponsored by Boehringer Ingelheim. Started Sep 2011; status: completed.
02
Drugs
dabigatran
03
Conditions
mechanical heart valvecardiac morbidity
Beyond the preview
Go deeper on 2011-002285-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002285-21.